There are a million reasons to go to Italy, so why do visitors always go to the same few places? Here are our favourite ways ...

The Chamber of Deputies approved the Infrastructure decreeby introducing an amendment that refers to a year the stop to the ...

The deal gives Merck access to Verona Pharma’s new chronic obstructive pulmonary disease medication Ohtuvayre.

Merck said on Wednesday it will acquire UK-based Verona Pharma for about $10 billion, gaining a promising respiratory treatment as it faces pressure to diversify beyond its blockbuster cancer drug ...

Merck is paying about $10 billion for Verona Pharma, expanding its respiratory disease drug portfolio.

Merck’s recent acquisition announcement sends a strong signal regarding its urgency to tackle the impending Keytruda patent cliff.

Get the latest Verona Pharma plc (VRNA) stock news and headlines to help you in your trading and investing decisions.